All terms in HP

Label Id Description
mesothelial cell of intestine CL_0008041 [A mesothelial cell that is part of the intestinal serosa.]
mesothelial cell CL_0000077 [A flat, squamous-like epithelial cell of mesodermal origin. It forms the mesothelium, which lines the body's serous cavities including the pleural, peritoneal, and pericardial spaces. This cell plays a crucial role in synthesizing and secreting lubricants, such as glycosaminoglycans and surfactants, which minimize friction between adjacent tissues during movement.]
Spherophakia HP_0034375 [Spherophakia is a rare congenital condition that presents with weak zonules around a more spherical crystalline lens with an increased anteroposterior thickness of the lens, and highly myopic eye. The lens zonules are developmentally hypoplastic and abnormally weak and due to non-attachment of the posterior zonules to the equatorial zone of the lens, the lens changes its normal shape to spherical.]
Abnormality of lens shape HP_0011526 [An abnormal shape of the lens.]
Atrioventricular valve regurgitation HP_0034376 [Regurgitation of a heart valve that controls blood flow from a an atrium to a ventricle, including mitral, tricuspid, or, rarely, single atrioventicular valve.]
Abnormal atrioventricular valve physiology HP_0031650 [Any functional defect of the mitral or tricuspid valve.]
Single atrioventricular valve regurgitation HP_0034377 [Regurgitation of the single atrioventricular valve regurgitation (AVVR) in the context of a congenital heart defect with a single ventricle. Roughly three quarters of patients following Fontan procedure display AVVR.]
Urethrovesical occlusion HP_0034378 [Blockage of the flow of urine from the bladder into the urethra.]
obsolete Vascular granular osmiophilic material deposition HP_0034379 [Accumulation of granular osmiophilic material in blood vessel walls. Osmiophilic material becomes black upon staining with osmium tetroxide.]
homotypic cell-cell adhesion GO_0034109 [The attachment of a cell to a second cell of the identical type via adhesion molecules.]
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor CHEBI_77119 [An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of prostaglandin-E2 9-reductase (EC 1.1.1.189).]
EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor CHEBI_76835 [An EC 1.1.* (oxidoreductase acting on donor CH-OH group) inhibitor that uses NAD(+) or NADP(+) as acceptor (EC 1.1.1.*).]
intracellular vesicle GO_0097708 [Any vesicle that is part of the intracellular region.]
vesicle GO_0031982 [Any small, fluid-filled, spherical organelle enclosed by membrane.]
intracellular membrane-bounded organelle GO_0043231 [Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.]
Decreased circulating prekallikrein concentration HP_0034371 [The concentration of prekallikrein in the blood circulation is below the lower limit of normal.]
Internal tibial torsion HP_0034372
External tibial torsion HP_0034373 [External twisting of the tibia resulting in the toes of each foot pointing outward (outtoeing) .]
ciliary basal body-plasma membrane docking GO_0097711 [The docking of a cytosolic centriole/basal body to the plasma membrane via the ciliary transition fibers. In some species this may happen via an intermediate step, by first docking to the ciliary vesicle via the ciliary transition fibers. The basal body-ciliary vesicle then relocates to the plasma membrane, followed by the ciliary vesicle fusing with the plasma membrane, effectively attaching the basal body to the plasma membrane.]
vesicle targeting, trans-Golgi to periciliary membrane compartment GO_0097712 [The process in which vesicles formed at the trans-Golgi network are directed to the plasma membrane surrounding the base of the cilium, including the ciliary pocket, mediated by molecules at the vesicle membrane and target membrane surfaces.]